KCTD10 Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NBP1-80086
Key Product Details
Species Reactivity
Human
Applications
Western Blot
Label
Unconjugated
Antibody Source
Polyclonal Rabbit IgG
Concentration
1 mg/ml
Product Specifications
Immunogen
Synthetic peptide directed towards the N terminal of human KCTD10. Peptide sequence MEEMSGESVVSSAVPAAATRTTSFKGTSPSSKYVKLNVGGALYYTTMQTL. The peptide sequence for this immunogen was taken from within the described region.
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Description
The addition of 50% glycerol is optional for those storing this antibody at -20C and not aliquoting smaller units. However, please note that glycerol may interrupt some downstream antibody applications and should be added with caution.
Scientific Data Images for KCTD10 Antibody
Western Blot: KCTD10 Antibody [NBP1-80086]
Western Blot: KCTD10 Antibody [NBP1-80086] - Jurkat cell lysate, concentration 1.25ug/ml.Applications for KCTD10 Antibody
Application
Recommended Usage
Western Blot
1.0 ug/ml
Formulation, Preparation, and Storage
Purification
Protein A purified
Formulation
PBS, 2% Sucrose
Preservative
0.09% Sodium Azide
Concentration
1 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: KCTD10
Alternate Names
BTB/POZ domain-containing adapter for CUL3-mediated RhoA degradation protein 3, BTB/POZ domain-containing protein KCTD10, FLJ41739, MSTP028, potassium channel tetramerisation domain containing 10, Potassium channel tetramerization domain-containing protein 10, ULR061, ULRO61
Gene Symbol
KCTD10
UniProt
Additional KCTD10 Products
Product Documents for KCTD10 Antibody
Product Specific Notices for KCTD10 Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...